We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$566M
AUM Growth
+$26.3M
Cap. Flow
+$4.1M
Cap. Flow %
0.72%
Top 10 Hldgs %
31.8%
Holding
320
New
24
Increased
113
Reduced
145
Closed
15

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3.18M
2
AZN icon
AstraZeneca
AZN
+$3.16M
3
LUMN icon
Lumen
LUMN
+$2.71M
4
PPL
PPL Corp
PPL
+$2.54M
5
KMB icon
Kimberly-Clark
KMB
+$2.52M

Sector Composition

Rank Sector Weight
1 Financials 12.56%
2 Industrials 11.86%
3 Healthcare 9.46%
4 Technology 7.68%
5 Consumer Discretionary 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
101
Mondelez International
MDLZ
$77.7B
$1.46M 0.26%
32,953
+546
+2% +$23.5K
HOLX
102
DELISTED
Hologic
HOLX
$1.42M 0.25%
35,347
-19
-0.1% -$733
LEN icon
103
Lennar Class A
LEN
$20.4B
$1.41M 0.25%
34,495
-4,991
-13% -$202K
IWR icon
104
iShares Russell Mid-Cap ETF
IWR
$56.8B
$1.39M 0.25%
31,176
+2,464
+9% +$108K
DVY icon
105
iShares Select Dividend ETF
DVY
$24B
$1.37M 0.24%
15,446
-175
-1% -$15.1K
PFE icon
106
Pfizer
PFE
$140B
$1.36M 0.24%
44,172
-2,900
-6% -$88.5K
VDE icon
107
Vanguard Energy ETF
VDE
$10.1B
$1.36M 0.24%
12,967
DHR icon
108
Danaher
DHR
$135B
$1.34M 0.24%
19,473
+113
+0.6% +$7.85K
META icon
109
Meta Platforms (Facebook)
META
$1.51T
$1.29M 0.23%
11,244
-14,979
-57% -$1.84M
CVX icon
110
Chevron
CVX
$388B
$1.29M 0.23%
10,946
-1,513
-12% -$165K
VUG icon
111
Vanguard Growth ETF
VUG
$216B
$1.29M 0.23%
69,288
BAC.PRL icon
112
Bank of America Series L
BAC.PRL
$3.95B
$1.26M 0.22%
1,084
RTX icon
113
RTX Corp
RTX
$287B
$1.26M 0.22%
18,239
-93
-0.5% -$6.16K
SDY icon
114
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$1.26M 0.22%
14,692
+8,141
+124% +$684K
PEP icon
115
PepsiCo
PEP
$186B
$1.25M 0.22%
11,994
+1,032
+9% +$108K
EPD icon
116
Enterprise Products Partners
EPD
$83.8B
$1.22M 0.22%
45,179
+8,893
+25% +$232K
BA icon
117
Boeing
BA
$165B
$1.22M 0.21%
7,813
+24
+0.3% +$3.5K
AVGO icon
118
Broadcom
AVGO
$1.82T
$1.16M 0.21%
65,870
-2,080
-3% -$36K
VTI icon
119
Vanguard Total Stock Market ETF
VTI
$654B
$1.16M 0.2%
10,057
MMP
120
DELISTED
Magellan Midstream Partners, L.P.
MMP
$1.15M 0.2%
15,147
-12
-0.1% -$840
PAYX icon
121
Paychex
PAYX
$40.4B
$1.14M 0.2%
18,664
-1,321
-7% -$76.1K
AMGN icon
122
Amgen
AMGN
$203B
$1.05M 0.19%
7,174
-1,638
-19% -$247K
BX icon
123
Blackstone
BX
$104B
$1.04M 0.18%
38,404
+2,041
+6% +$53K
NEE icon
124
NextEra Energy
NEE
$187B
$1.04M 0.18%
34,684
+308
+0.9% +$9.2K
TXN icon
125
Texas Instruments
TXN
$255B
$1.03M 0.18%
14,104
-2,443
-15% -$174K

Similar funds

Corient Capital Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Corient Capital Partners held 320 positions worth $566M, up 4.9% from $540M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Corient Capital Partners's Q4 2016 filing shows 24 new, 113 increased, 145 reduced and 15 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 121,417 shares worth $6.28M. The largest sale was Eli Lilly, an estimated $3.18M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Industrials and Healthcare.

  • Corient Capital Partners's largest Q4 2016 buy was State Street Consumer Staples Select Sector SPDR ETF: 121,417 shares worth $6.28M.
  • Corient Capital Partners added most to State Street Health Care Select Sector SPDR ETF in Q4 2016, an estimated $6.76M increase.
  • Corient Capital Partners's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $3.18M.
  • Corient Capital Partners fully exited Macy's in Q4 2016, selling an estimated $1.89M.
  • Corient Capital Partners's ten largest holdings make up 32% of its $566M portfolio in Q4 2016.
  • Corient Capital Partners opened 24 new positions and closed 15 in Q4 2016.
  • Corient Capital Partners's portfolio value rose 4.9% quarter-over-quarter to $566M.

Based on Corient Capital Partners's 13F filing for Q4 2016, filed 10 Feb 2017.